According to Fox News, Marjorie Taylor Greene criticized the FDA's approval of the mNEXSPIKE COVID-19 vaccine, expressing concerns over regulatory decisions. For traders, this highlights increased scrutiny on biotech stocks, potentially leading to short-term volatility in related equities (source: Fox News). Crypto traders should watch for spillover sentiment into digital asset markets, as regulatory debates over health tech can influence broader risk appetite and tokenized biotech projects.